NCT01442636View on ClinicalTrials.gov

Drug Eluting Stents In The Critically Ischemic Lower Leg 2

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2014

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

stent

Implantation of one or more Everolimus-eluting XIENCE PRIME™ Everolimus Eluting Coronary Stent Systems.

Trial Locations (6)

2031

Prince of Wales Private Hospital, Randwick

2820

Imelda Hospital, Bonheiden

9200

Department Vascular Surgery, A.Z. Sint-Blasius Hospital, Dendermonde

48145

St Fransiskus hospital, Münster

79189

Herz-zentrum Bad Krozingen, Bad Krozingen

04289

Herzzentrum, Leipzig

All Listed Sponsors
lead

Flanders Medical Research Program

NETWORK

NCT01442636 - Drug Eluting Stents In The Critically Ischemic Lower Leg 2 | Biotech Hunter | Biotech Hunter